2119 Visualization of micro-vasculature using FeCo-core/graphitic-carbon-shell nanocrystals and high-resolution 3D spiral imaging by Jin Lee et al.
BioMed Central
Journal of Cardiovascular Magnetic 
Resonance
ssOpen AcceMeeting abstract
2119 Visualization of micro-vasculature using 
FeCo-core/graphitic-carbon-shell nanocrystals and high-resolution 
3D spiral imaging
Jin Hyung Lee*, Masahiro Terashima, Won Seok Seo, Hisanori Kosuge, 
Sarah Sherlock, Michael McConnell, Dwight Nishimura and Hongjie Daiv
Address: Stanford University, Stanford, CA, USA
* Corresponding author    
Introduction
Non-invasive visualization of small vessel structures has
been difficult due to insufficient contrast between small
vessels and background tissue, and limited spatial resolu-
tion of MRI. Here, we present a method to non-invasively
visualize small vascular structures in-vivo, in live animals
using novel contrast agents combined with fast, high res-
olution image encoding methods.
Purpose
To evaluate the use of 1) the FeCo-Core/Graphitic-Car-
bon-Shell nanocrystal contrast agent [1] and 2) the high
resolution encoding enabled by 3D spiral acquisition and
small surface coils for the visualization of microvascula-
ture in-vivo.
Methods
Normal and stenosis induced white rabbits with body
weight of ~4 kg were first catheterized in the ear vein.
Through the catheter, 9.6 cc of 5 mM concentration FeCo
nanocrystal contrast agent was injected followed by 1 cc of
saline injection. Immediately before and after the injec-
tion, a small volume covered by a 1 inch custom made
surface coil was imaged using spectral-spatial excitation
and 3D spiral readout. The spatial resolution was 78 × 78
× 500 um3 with volume coverage of 4 × 4 × 1 cm3. The
scan time was 2 min 40 sec for a single volume and the
scan was repeated 9 times over 24 min to improve SNR. A
whole body volume scan using a fat-saturated 3D SPGR
sequence was also performed using a standard GE head
coil 1 hour before and after the injection. All the experi-
ments were conducted using a GE 1.5 T EXCITE whole
body system with a maximum gradient of 40 mT/m and
maximum slew rate of 150 T/m/s.
Results
The FeCo nanocrystal contrast agent's ability to produce
high enhancement with 0.2 mM blood concentration
which is 10% of Gd (Magnevist) dosage is demonstrated
in Fig. 1. Enhancement factor of 9 is achieved (Figure 1b,
c) as expected from the relaxivity parameters (Figure 1a).
The aortic stenosis can also be clearly observed in Fig. 1b.
With this strong enhancement and high resolution acqui-
sition, small vessels down to 78 um in diameter were suc-
cessfully visualized in-vivo (Figure. 2b).
Conclusion
The FeCo contrast agent provides several advantages for
high resolution vessel imaging; strong relaxivity, relatively
long circulation time compared to conventional Gd based
contrast agent, and small nano-scale size. These properties
allow sufficient contrast in the small vessels for a long
enough time to acquire high resolution images. The high
resolution 3D spiral imaging technique combined with
this FeCo contrast agent demonstrates great potential to
visualize microvasculature in-vivo.
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In this paper, we present a method to non-invasively vis-
ualize small vascular structures (~78 um) in-vivo, in live
animals using novel FeCo-Core/Graphitic-Carbon-Shell
nanocrystal contrast agents combined with fast, high res-
olution 3D spiral encoding methods.
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Maximal intensity projection (MIP) of the vessel images in the rabbit leg (a) before con rast injection, and (b) i mediately after contr st injecti nFigure 2
Maximal intensity projection (MIP) of the vessel images in the 
rabbit leg (a) before contrast injection, and (b) immediately 
after contrast injection.
The relaxivity parameters of various contrast agents indicate that with the SPGR acquisition, 0.2 mM blood concentration can produce 9 fold signal enhancement with he FeCo nanocrystal based contrast agent (a)Figu e 1
The relaxivity parameters of various contrast agents indicate that with the SPGR acquisition, 0.2 mM blood concentration can 
produce 9 fold signal enhancement with the FeCo nanocrystal based contrast agent (a). The predictions are confirmed in (b), 
(c) and (b) also shows a nice depiction of the aortic stenosis.Page 2 of 2
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